Wednesday, January 02, 2019 4:48:27 PM
I'm fairly sure the answer to #3 is No. Almost certain in fact, based all that I've read about it over these many months. I'd love to know the answers to the other two right along with the rest of you, #2 especially.
And as far as the patent PR is concerned, seeing as that has been confirmed for a while now, I am much more interested in the trial completion and test results and their implications than I am about a patent PR. As a result, if there is a PR specifically for the patent, I will be looking eagerly to what if anything they might say in addition.
GLTA
And as far as the patent PR is concerned, seeing as that has been confirmed for a while now, I am much more interested in the trial completion and test results and their implications than I am about a patent PR. As a result, if there is a PR specifically for the patent, I will be looking eagerly to what if anything they might say in addition.
GLTA
Recent SHMP News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 10:26:09 AM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 03/20/2026 03:09:50 PM
- Form PRER14C - Information statements • Edgar (US Regulatory) • 03/09/2026 11:09:28 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 05:10:54 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 12/23/2025 01:00:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 11/05/2025 08:22:57 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/10/2025 07:22:12 PM
